Skip to content

LOROPHAR

Active Private limited companyfounded 2010active for 16 yearsRue de Linsmeau 4, 4287 LincentKBO/BCE: BE 0829.202.322

Lifetime

15 annual accounts with figures on one time axis
peak of €117,420 in 2014
€104,652▲ 79.1%
lowest -€626 in 2022
€44,679▲ 231%
peak of €109,031 in 2025
€109,031▲ 21.2%
€125,268▲ 8.5%
peak of 0.7 FTE in 2020
-not published
Board2 names since 2010
2 directors and 1 other
Documentsfilings and deeds
14-08-202614 days late
2025micro format
Gross margin from €58,445 to €104,652Result from €13,482 to €44,679Dividend €25,623Equity from €89,975 to €109,031Cash from €44,020 to €74,319

Key points

from the 2025 annual accounts

Equity

€109,031 ▲ 21.2%
89,9752024+44,679Profit-25,623Dividend109,0312025

LOROPHAR paid out €25,623 in dividends. That is 57% of the 2025 profit.

Filings

15 annual accounts since 2011
AprilJune31 JulyOctober201520202025

Seven of the last ten came late. The 2019 accounts came in latest, 34 days after the end of the period.

Position in the sector

€44,679

Higher net result than 86% of companies in retail trade. The sector median is €4,724, over 25,359 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,726 companies had the same profile as LOROPHAR has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,726 companies, not a prediction for LOROPHAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0829202322
changes role from manager to director Discharge granted to (manager) · General meeting of 13-04-2023 · Gazette deed
is in office as manager Gazette deed
Incorporation Founded by · Founding capital of €18,600, 186 shares, €12,400 paid up · appointed as manager · published on 22-09-2010 · Gazette deed
All 25 events

Comparable companies

same main activity, similar in size and age
Company
LOROPHAR Lincent €234,299 €104,652 46.5% -
VROOME PHARMA MANAGEMENT Antwerp €229,894 €105,378 42.6% -
ATOUPHAR Flémalle €260,410 €114,236 58.7% -
FARMAFENDER Zedelgem €269,880 €95,126 62.8% -
NIMY PHAR Mons €259,917 €88,747 -72.9% -
Pharmacie-Herboristerie SEGERS Vielsalm €231,074 €86,385 40.8% -
Pharmacie la Licorne Brussels €266,053 €92,684 55.3% -

These companies have the same main activity as LOROPHAR: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €230,000 and €270,000, founded between 2009 and 2012.

Official details

Source: KBO
Status
Active since 13-09-2010Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2022
Establishment unit
2.193.129.5174287 Lincent, since 13-09-2010
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

≈ €370,000estimated
€234,299▲ 14.0%
Employeeson 31-12-2025
1=
Filing
Filed on 14-08-2026
Financials

Insights on LOROPHAR

LOROPHAR files the micro format. That format states no turnover. The gross margin fell from €111,392 in 2011 to €104,652 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about LOROPHAR

What is the company number of LOROPHAR?
The company number of LOROPHAR is 0829.202.322. The VAT number is the same number with BE in front: BE 0829.202.322.
Where is LOROPHAR based?
The registered office is at Rue de Linsmeau 4, 4287 Lincent.Company details
What does LOROPHAR do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of LOROPHAR?
LOROPHAR is a private limited company (BV).
When was LOROPHAR founded?
LOROPHAR was founded on 13-09-2010.
Is LOROPHAR still active?
Yes, LOROPHAR is an active enterprise in the KBO register.
How many employees does LOROPHAR have?
LOROPHAR had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does LOROPHAR fall under?
In its 2022 annual accounts, LOROPHAR states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of LOROPHAR?
The turnover in financial year 2025 is about €370,000. This figure is estimated from the gross margin of €104,652 and 37 comparable companies (NACE 477). It probably lies between €270,000 and €620,000.
Is LOROPHAR profitable?
In financial year 2025, LOROPHAR made a profit of €44,679.
Where can I find the annual accounts of LOROPHAR?
LOROPHAR filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of LOROPHAR due?
LOROPHAR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.